Contribution of Idasanutlin Exposure to Safety, Pharmacodynamics and Clinical Response of Patients with Acute Myeloid Leukemia Treated with Idasanutlin + Cytarabine in Phase I and III Studies
- Resource Type
- Abstract
- Source
- In
Blood 5 November 2020 136 Supplement 1:7-8 - Subject
- Language
- ISSN
- 0006-4971